BLANCHE KATTIE: Open Payments
NPI 1013426824 · PIKESVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,214 in 46 payments from 12 companies in 2025. Trend: 2023 $1,112 · 2024 $1,001 · 2025 $1,214
Food & beverage: $1,214
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $210 |
| Axsome Therapeutics, Inc. | 6 | $206 |
| ABBVIE INC. | 8 | $166 |
| Alkermes, Inc. | 6 | $166 |
| E.R. Squibb & Sons, L.L.C. | 4 | $164 |
| Supernus Pharmaceuticals, Inc. | 6 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Lundbeck LLC | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: FANAPT, Auvelity, VRAYLAR, COBENFY, LYBALVI, Qelbree, CAPLYTA, REXULTI.
Industry payments across MD — which companies pay providers there.
